Peptide Initiative

Peptides · Peptide comparison

Acetyl Hexapeptide-3 (Argireline) vs Palmitoyl Tetrapeptide-7

SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.

Anti-inflammatory matrikine peptide that reduces IL-6-driven inflammaging for calmer, more youthful skin.

  • Cosmetic
  • Cosmetic

At a glance

Quick comparison

Dose rangeAcetyl Hexapeptide-3 (Argireline)5–10 %Palmitoyl Tetrapeptide-73–3 %
FrequencyAcetyl Hexapeptide-3 (Argireline)Once dailyPalmitoyl Tetrapeptide-7Once daily
AdministrationAcetyl Hexapeptide-3 (Argireline)TopicalPalmitoyl Tetrapeptide-7Topical
Cycle lengthAcetyl Hexapeptide-3 (Argireline)Ongoing/indefinitePalmitoyl Tetrapeptide-7Ongoing/indefinite
Onset speedAcetyl Hexapeptide-3 (Argireline)Moderate (1-2 weeks)Palmitoyl Tetrapeptide-7Moderate (1-2 weeks)
Evidence levelAcetyl Hexapeptide-3 (Argireline)Limited human trialsPalmitoyl Tetrapeptide-7Limited human trials

Efficacy

Benefit ratings

Expression Wrinkle Reduction

Acetyl Hexapeptide-3 (Argireline)85%
Palmitoyl Tetrapeptide-7No recorded rating

Non-Invasive Treatment

Acetyl Hexapeptide-3 (Argireline)92%
Palmitoyl Tetrapeptide-7No recorded rating

Safety Profile

Acetyl Hexapeptide-3 (Argireline)95%
Palmitoyl Tetrapeptide-7No recorded rating

Anti-Inflammatory

Acetyl Hexapeptide-3 (Argireline)No recorded rating
Palmitoyl Tetrapeptide-788%

Anti-Aging

Acetyl Hexapeptide-3 (Argireline)No recorded rating
Palmitoyl Tetrapeptide-782%

Skin Barrier Support

Acetyl Hexapeptide-3 (Argireline)No recorded rating
Palmitoyl Tetrapeptide-780%

Technical data

Compound specifications

Acetyl Hexapeptide-3 (Argireline)

Molecular formula
C35H62N14O11S
Molecular weight
887.0 Da
Half-life
Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
Bioavailability
Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
CAS number
616204-22-9

Palmitoyl Tetrapeptide-7

Molecular formula
C34H62N8O7
Molecular weight
694.9 Da
Half-life
Susceptible to enzymatic degradation; palmitoyl anchor reduces proteolytic cleavage rate compared to unmodified peptide
Bioavailability
Enhanced topical penetration via palmitoyl lipid modification enabling membrane interaction and dermal delivery
CAS number
221227-05-0

Protocols

Dosing compared

Acetyl Hexapeptide-3 (Argireline)

Topical

  • 5-10% concentration (cream or serum)Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effectUsed as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]

Palmitoyl Tetrapeptide-7

Topical

  • Under 10 ppm (<0.001%) in finished productOnce or twice daily · OngoingCustomary leave-on cosmetic use is below 10 ppm of the active peptide [6]. Pal-GQPR is almost always used as a co-active alongside Pal-GHK in the Matrixyl 3000 blend rather than on its own.
  • ~3% trade solution (Matrixyl 3000 blend)Twice daily · ~2 monthsIn manufacturer clinical testing the trade-solution blend was applied twice daily for about two months [6]. The ~3% figure refers to the diluted trade solution, which contains only ppm-level active peptide.

Applications

Best suited for

Acetyl Hexapeptide-3 (Argireline)

Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][4].
Those with needle phobia who want botulinum toxin-like effects without injections
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4].
People targeting crow's feet, forehead lines, and glabellar creases
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Palmitoyl Tetrapeptide-7

Individuals with aging skin showing signs of chronic low-grade inflammation
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with aging skin showing signs of chronic low-grade inflammation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those seeking to reduce UV-damage-related skin aging (photoaging)
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on those seeking to reduce uv-damage-related skin aging (photoaging). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for synergistic peptide therapy in Matrixyl 3000 products
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on people looking for synergistic peptide therapy in matrixyl 3000 products. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety profile

Side effects

Acetyl Hexapeptide-3 (Argireline)

Common

  • Mild Skin Irritation
  • Transient Redness
  • Slight Dryness
  • Stinging on Compromised Skin

Uncommon

  • Contact Dermatitis

Serious

  • Allergic Contact Dermatitis

Palmitoyl Tetrapeptide-7

Common

  • Mild Redness
  • Slight Tingling
  • Mild Irritation with Other Actives
  • Dryness

Uncommon

  • Allergic Contact Dermatitis

Serious

  • Paradoxical Inflammatory Response

Research status

Safety & evidence

Acetyl Hexapeptide-3 (Argireline)

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. In cell-culture testing, significant cytotoxicity appeared only at concentrations 18 to 10,000 times higher than the reference drug doxorubicin [5]. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.

Contraindications

  • Known hypersensitivity to acetyl hexapeptide-3 or formulation components
  • Active skin infections or open wounds at the application site
  • No known systemic contraindications at cosmetic concentrations
  • Use with caution in individuals with neuromuscular disorders (theoretical concern)

Palmitoyl Tetrapeptide-7

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Palmitoyl tetrapeptide-7 (Eyeliss) shows excellent safety for periocular use with minimal irritation potential (Draize score <0.5 at 2% concentration). No serious adverse events in cosmetic formulations used for 15+ years. Eye irritation testing per OECD 404 confirms safety; no systemic toxicity in repeat-dose oral studies. Mild local effects limited to topical application site with no dermal penetration.

Contraindications

  • Known hypersensitivity to palmitoyl tetrapeptide-7 or formulation excipients
  • Active skin infections at the application site
  • Severely compromised skin barrier with active inflammation requiring medical intervention
  • No known systemic contraindications at cosmetic concentrations

Decision guide

Which is right for you?

Acetyl Hexapeptide-3 (Argireline)

Choose Acetyl Hexapeptide-3 (Argireline) if…

  • Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
  • Those with needle phobia who want botulinum toxin-like effects without injections
  • People targeting crow's feet, forehead lines, and glabellar creases
  • Individuals looking for preventive anti-wrinkle treatment to slow expression line formation

Palmitoyl Tetrapeptide-7

Choose Palmitoyl Tetrapeptide-7 if…

  • Individuals with aging skin showing signs of chronic low-grade inflammation
  • Those seeking to reduce UV-damage-related skin aging (photoaging)
  • People looking for synergistic peptide therapy in Matrixyl 3000 products
  • Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides